Businesses
Here's a look at documents from U.S. and international businesses
Featured Stories
JULAC and Taylor & Francis sign open access agreement to boost the impact of Hong Kong research
LONDON, England, Jan. 12 [Category: BizMedia] -- Taylor and Francis Group, a publishing company, posted the following news release:
* * *
JULAC and Taylor & Francis sign open access agreement to boost the impact of Hong Kong research
*
First Taylor & Francis partnership with Hong Kong's university library consortium supports open access publishing and global research sharing: Photolink Ltd via Alamy
Researchers in Hong Kong will have greater opportunities to share their work with a global audience through a new open access (OA) agreement between the Joint University Librarians Advisory Committee
... Show Full Article
LONDON, England, Jan. 12 [Category: BizMedia] -- Taylor and Francis Group, a publishing company, posted the following news release:
* * *
JULAC and Taylor & Francis sign open access agreement to boost the impact of Hong Kong research
*
First Taylor & Francis partnership with Hong Kong's university library consortium supports open access publishing and global research sharing: Photolink Ltd via Alamy
Researchers in Hong Kong will have greater opportunities to share their work with a global audience through a new open access (OA) agreement between the Joint University Librarians Advisory Committee(JULAC) and Taylor & Francis.
The three-year agreement enables researchers at all participating institutions to publish OA articles in over 2,000 Taylor & Francis and Routledge Open Select (hybrid) journals without payment of an OA article publishing charge. Articles will be open on publication and free to access and reuse for readers around the world, broadening the reach of Hong Kong's research.
Research fields with otherwise limited funding for OA publishing will receive a particular boost from the partnership, especially the Humanities and Social Sciences where Taylor & Francis is a leading global publisher. Additionally, the agreement ensures that faculty and students at participating universities retain access to Taylor & Francis' extensive journal portfolio.
Beyond enhancing the visibility of Hong Kong's research, this first OA agreement between Taylor & Francis and JULAC aims to streamline institutional support for OA publishing. Librarians at participating universities will gain access to insights and reports via the Taylor & Francis OA Dashboard, operational assistance, and on-demand training.
"As made clear in JULAC's Position Statement on Open Scholarship, JULAC is committed to enabling open access to research publications. This agreement with Taylor & Francis is an example of the tangible support that libraries can provide to their institution's researchers in making their work OA," said Sidney Cheng, JULAC Chair and University Librarian, The Education University of Hong Kong.
Ian Jones, VP and Commercial Lead at Taylor & Francis, said: "Hong Kong's institutions and researchers have long championed OA and its ability to drive global impact. This new agreement developed in collaboration with our partners at JULAC will enable the publication of hundreds more OA articles every year, ensuring readers everywhere can benefit from Hong Kong's world-class research."
About JULAC
The Joint University Librarians Advisory Committee was established in 1967 by the Heads of Universities Committee. It is a forum to discuss, coordinate, and collaborate on library information resources and services among the libraries of the eight tertiary education institutions funded by the University Grants Committee of the Hong Kong SAR Government.
About Taylor & Francis
Taylor & Francis supports diverse communities of experts, researchers and knowledge makers around the world to accelerate and maximize the impact of their work. We are a leader in our field, publish across all disciplines and have one of the largest Humanities and Social Sciences portfolios. Our expertise, built on an academic publishing heritage of over 200 years, advances trusted knowledge that fosters human progress.
Our 2,400+ people, based in a global network of offices in more than 15 countries, use their skills and the latest technology to curate, validate and share impactful advanced, emergent and applied knowledge. Under the Taylor & Francis, Routledge and F1000 imprints, we publish over 2,500 journals, 8,400 new books each year and partner with more than 700 scholarly societies.
Taylor & Francis is proud to be a Global Certified Accessible(tm) publisher and to have achieved CarbonNeutral(r) certification for our operations and print publications in accordance with The CarbonNeutral Protocol.
Media contacts
Taylor & Francis : Mark Robinson, mark.robinson@tandf.co.uk
The Chinese University of Hong Kong : Seth KWOK, sethkwok@cuhk.edu.hk
City University of Hong Kong : CityUHK Library - Open Access Services, lbopen@cityu.edu.hk
The Education University of Hong Kong : Michelle YIU, myhyiu@eduhk.hk
Hong Kong Baptist University : Christina WU, christinawu@hkbu.edu.hk
The Hong Kong Polytechnic University : Janice CHIA, janice.chia@polyu.edu.hk
The Hong Kong University of Science and Technology : Library Research Support Team, lbrs@ust.hk
Lingnan University : Louisa LAM, louisalam@ln.edu.hk
The University of Hong Kong : Kenie TONG (for content), kenutong@hku.hk and KWAN Yin Yee, yinyeek@hku.hk
***
Original text here: https://newsroom.taylorandfrancisgroup.com/julac-and-taylor-and-francis-sign-open-access-agreement/
Premium Matchups Headline 2026 Sunday Night Baseball Schedule as MLB Returns to NBC and Peacock
NEW YORK, Jan. 10 [Category: BizMedia] -- NBCUniversal, a subsidiary of Comcast, posted the following news:
* * *
Premium Matchups Headline 2026 Sunday Night Baseball Schedule as MLB Returns to NBC and Peacock
Reigning MVPs Shohei Ohtani and Aaron Judge, storied rivalries, top division matchups, and '25 Postseason Clubs meeting in a scorching summer stretch of five consecutive NBC Sunday nights (June 28-Aug. 2) highlight NBC Sports ' 2026 Major League Baseball schedule.
NBC Sports' 2026 MLB schedule features:
* 27 primetime games, a mixture of Sunday Night Baseball and holiday/special event
... Show Full Article
NEW YORK, Jan. 10 [Category: BizMedia] -- NBCUniversal, a subsidiary of Comcast, posted the following news:
* * *
Premium Matchups Headline 2026 Sunday Night Baseball Schedule as MLB Returns to NBC and Peacock
Reigning MVPs Shohei Ohtani and Aaron Judge, storied rivalries, top division matchups, and '25 Postseason Clubs meeting in a scorching summer stretch of five consecutive NBC Sunday nights (June 28-Aug. 2) highlight NBC Sports ' 2026 Major League Baseball schedule.
NBC Sports' 2026 MLB schedule features:
* 27 primetime games, a mixture of Sunday Night Baseball and holiday/special eventgames on NBC/ Peacock and Peacock/ NBCSN
* 34 afternoon games across NBC/Peacock and Peacock/NBCSN, highlighted by 18 MLB Sunday Leadoff games on Peacock, most with noon start times locally
* A Sunday afternoon whip-around show on Peacock following MLB Sunday Leadoff games, featuring look-ins at all the live action around Major League Baseball, plus a special final day of regular season whip-around show on Sunday, Sept. 27 on Peacock and NBCSN
* One out-of-market game each day of the season streamed nationally on Peacock
* Special July 5 "Star-Spangled Sunday" featuring all 15 MLB games exclusively presented nationally on Peacock and NBC
* Exclusive coverage of the entire Wild Card round ignites the MLB Postseason on NBC, Peacock and NBCSN (8-12 games)
With the addition of Sunday Night Baseball, NBC will deliver year-round primetime sports programming on the same night each week - a broadcast network first - joining NBC Sports' presentations of Sunday Night Football (NFL) and Sunday Night Basketball (NBA).
Highlights of NBC Sports' 2026 Major League Baseball Schedule
* Major League Baseball returns to NBC and Peacock with a showcase package of exclusive games and events highlighted by the World Series champion Los Angeles Dodgers raising their banner leading into a primetime matchup (vs. Arizona Diamondbacks) on March 26, 2026 - the first full day of games in the 2026 MLB season. The Dodgers' opener will be the only primetime MLB game on Opening Day.
* NBC Sports presents an Opening Day matinee (March 26 at 1 p.m. ET on NBC and Peacock), as 2025 NL Cy Young winner Paul Skenes and the Pittsburgh Pirates visit Juan Soto and the New York Mets.
* Sunday Night Baseball debuts March 29 at 7 p.m. ET on Peacock/NBCSN, with a matchup of American League division winners as the Cleveland Guardians visit the Seattle Mariners.
* MLB Sunday Leadoff on Peacock and NBCSN begins on May 3 as the American League champion Toronto Blue Jays visit the Minnesota Twins.
* 2025 MLB Postseason Clubs in primetime include four appearances apiece by the World Champion Los Angeles Dodgers, Boston Red Sox and San Diego Padres, and three primetime games each for the New York Yankees, Philadelphia Phillies, Detroit Tigers, and Seattle Mariners.
* In mid-July, young players will be highlighted as NBC and Peacock present early first-round coverage of the MLB Draft at 1:30 p.m. ET on Saturday, July 11, and the All-Star Futures Game at Noon ET on Sunday, July 12.
Division Rivalries in Primetime
Sunday Night Baseball will be home to division rivalry games including Diamondbacks-Dodgers (March 26); Braves-Phillies (April 19); Tigers-Royals (May 10); Rangers-Angels (May 24); Cubs-Cardinals (May 31); Mets-Phillies (June 21); Yankees-Red Sox (June 28); Padres-Dodgers (July 5); Mariners-Astros (August 16); and Padres-Giants (Sept. 13).
Spanish-Language Coverage for all NBCU-Produced Games
Universo will televise all games broadcast on NBC, and SAP will be provided for all games on Peacock.
2026 Sunday Night Baseball & Special Event Schedule
**All Times ET**
**NOTE: Most Peacock Exclusive Games Will Be Simulcast on NBCSN
Date
Time
Game
Platforms
March 26*
1 p.m.
Pittsburgh Pirates at N.Y. Mets
NBC/Peacock
March 26*
8 p.m.
Arizona Diamondbacks at L.A. Dodgers
NBC/Peacock
March 29
7 p.m.
Cleveland Guardians at Seattle Mariners
Peacock
April 5
7 p.m.
St. Louis Cardinals at Detroit Tigers
Peacock
April 12
7 p.m.
Cleveland Guardians at Atlanta Braves
NBC/Peacock
April 19
7 p.m.
Atlanta Braves at Philadelphia Phillies
Peacock
April 26
7 p.m.
L.A. Angels at Kansas City Royals
Peacock
May 3
7 p.m.
Texas Rangers at Detroit Tigers
Peacock
May 10
7 p.m.
Detroit Tigers at Kansas City Royals
Peacock
May 17
7 p.m.
San Diego Padres at Seattle Mariners
Peacock
May 24
7 p.m.
Texas Rangers at L.A. Angels
Peacock
May 31
7 p.m.
Chicago Cubs at St. Louis Cardinals
NBC/Peacock
June 7
8 p.m.
San Francisco Giants at Chicago Cubs
NBC/Peacock
June 14
7 p.m.
Texas Rangers at Boston Red Sox
NBC/Peacock
June 21
7 p.m.
N.Y. Mets at Philadelphia Phillies
NBC/Peacock
June 28
7 p.m.
N.Y. Yankees at Boston Red Sox
NBC/Peacock
July 5**
12:30 p.m.
N.Y. Mets at Atlanta Braves
NBC/Peacock
July 5
7 p.m.
San Diego Padres at L.A. Dodgers
NBC/Peacock
July 19
7 p.m.
L.A. Dodgers at N.Y. Yankees
NBC/Peacock
July 26
7 p.m.
N.Y. Yankees at Philadelphia Phillies
NBC/Peacock
August 2
7 p.m.
Boston Red Sox at L.A. Dodgers
NBC/Peacock
August 9
8 p.m.
Houston Astros at San Diego Padres
NBC/Peacock
August 16
7 p.m.
Seattle Mariners at Houston Astros
NBC/Peacock
August 23
3 p.m.
San Francisco Giants at Boston Red Sox
NBC/Peacock
August 30
3 p.m.
Cincinnati Reds at Chicago Cubs
NBC/Peacock
August 30
7 p.m.
Houston Astros at N.Y. Mets
NBC/Peacock
Sept. 6
3 p.m.
Atlanta Braves at Philadelphia Phillies
NBC/Peacock
Sept. 6
7 p.m.
Toronto Blue Jays at Kansas City Royals
Peacock
Sept. 7
8 p.m.
St. Louis Cardinals at San Francisco Giants
NBC/Peacock
Sept. 13
7 p.m.
San Diego Padres at San Francisco Giants
Peacock
Sept. 20
7 p.m.
Milwaukee Brewers at Baltimore Orioles
Peacock
*Opening Day (Thursday)
**Also on MLB Sunday Leadoff schedule ( below )
***Labor Day (Monday)
2026 MLB Sunday Leadoff Schedule
**All Times ET**
**NOTE: Most Peacock Exclusive Games Will Be Simulcast on NBCSN
Date
Time
Game
Platforms
May 3
12:30 p.m.
Toronto Blue Jays at Minnesota Twins
Peacock
May 10
Noon
Washington Nationals at Miami Marlins
Peacock
May 17
Noon
Miami Marlins at Tampa Bay Rays
Peacock
May 24
Noon
Pittsburgh Pirates at Toronto Blue Jays
Peacock
May 31
Noon
Toronto Blue Jays at Baltimore Orioles
Peacock
June 7
3 p.m.
Washington Nationals at Arizona Diamondbacks
Peacock
June 14
Noon
Miami Marlins at Pittsburgh Pirates
Peacock
June 21
3 p.m.
Minnesota Twins at Arizona Diamondbacks
Peacock
June 28
3 p.m.
Athletics at L.A. Angels
Peacock
July 5
12:30 p.m.
N.Y. Mets at Atlanta Braves
NBC/Peacock
July 12
Noon
Milwaukee Brewers at Pittsburgh Pirates
Peacock
July 19
Noon
Chicago White Sox at Toronto Blue Jays
Peacock
July 26
Noon
Cleveland Guardians at Tampa Bay Rays
Peacock
August 2
3 p.m.
Milwaukee Brewers at L.A. Angels
Peacock
August 9
Noon
Cincinnati Reds at Washington Nationals
Peacock
August 16
Noon
Baltimore Orioles at Tampa Bay Rays
Peacock
August 23
4 p.m.
Cincinnati Reds at Arizona Diamondbacks
Peacock
August 30
Noon
Miami Marlins at Washington Nationals
Peacock
NBC Sports' July 5 MLB "Star-Spangled Sunday"
Every MLB Game presented nationally on NBCUniversal platforms
**All Times ET**
**NOTE: Most Peacock Exclusive Games Will Be Simulcast on NBCSN
Time
Game
Platforms
12:30 p.m.*
N.Y. Mets at Atlanta Braves
NBC/Peacock
1 p.m.
Pittsburgh Pirates at Washington Nationals
Peacock
1 p.m.
Baltimore Orioles at Cincinnati Reds
Peacock
1:30 p.m.
Minnesota Twins at New York Yankees
Peacock
2 p.m.
Chicago White Sox at Cleveland Guardians
Peacock
2:30 p.m.
St. Louis Cardinals at Chicago Cubs
Peacock
3 p.m.
Philadelphia Philles at Kansas City Royals
Peacock
3:30 p.m.
Detroit Tigers at Texas Rangers
Peacock
3:30 p.m.
Tampa Bay Rays at Houston Astros
Peacock
4:00 p.m.
San Francisco Giants at Colorado Rockies
Peacock
4:00 p.m.
Milwaukee Brewers at Arizona Diamondbacks
Peacock
4:30 p.m.
Miami Marlins at Athletics
Peacock
5:00 p.m.
Toronto Blue Jays at Seattle Mariners
Peacock
7 p.m. **
San Diego Padres at L.A. Dodgers
NBC/Peacock
9:30 p.m.
Boston Red Sox at Los Angeles Angels
Peacock
* MLB Sunday Leadoff
** Sunday Night Baseball
***
Original text here: https://www.nbcuniversal.com/article/ohtani-judge-yankees-red-sox-dodgers-yankees-cubs-cardinals-and-additional-premium-matchups-headline
Optimum Mobile Expands Device Lineup With the All-New Samsung Galaxy Tab A11+ 5G and Samsung Galaxy A17 5G
LONG ISLAND CITY, New York, Jan. 10 -- Optimum, a subsidiary of Altice USA, issued the following news release:
* * *
Optimum Mobile Expands Device Lineup with the All-New Samsung Galaxy Tab A11+ 5G and Samsung Galaxy A17 5G
Optimum Mobile is excited to announce the addition of two new Samsung devices to its portfolio: the Samsung Galaxy Tab A11+ 5G and the Samsung Galaxy A17 5G, delivering next-generation connectivity and productivity to customers nationwide.
The Samsung Galaxy Tab A11+ 5G features a vibrant 11" display, industry-leading processor, and advanced Galaxy AI capabilities designed
... Show Full Article
LONG ISLAND CITY, New York, Jan. 10 -- Optimum, a subsidiary of Altice USA, issued the following news release:
* * *
Optimum Mobile Expands Device Lineup with the All-New Samsung Galaxy Tab A11+ 5G and Samsung Galaxy A17 5G
Optimum Mobile is excited to announce the addition of two new Samsung devices to its portfolio: the Samsung Galaxy Tab A11+ 5G and the Samsung Galaxy A17 5G, delivering next-generation connectivity and productivity to customers nationwide.
The Samsung Galaxy Tab A11+ 5G features a vibrant 11" display, industry-leading processor, and advanced Galaxy AI capabilities designedto simplify everyday tasks. With lightning-fast 5G connectivity, users can stream, work, and play wherever life takes them. Key features include an immersive FHD+ display, a powerful 4nm processor, and enhanced battery life for all-day productivity. The new Galaxy AI features support smarter organization, translation, and creativity, all within a sleek, modern design perfect for work, school, and entertainment.
The Samsung Galaxy A17 5G brings incredible value and essential features at an awesome price. Capture precious memories in vivid colors and clarity with its enhanced triple-lens camera and Optical Image Stabilization. Stream your favorite movies and shows on its crystal-clear 6.7" Super AMOLED display. With the power of AI, including Gemini and Circle to Search, planning events, making reservations, and finding gifts is easier than ever. Enjoy reliable Super Fast Charging, up to 2TB of expandable storage, and ultra-fast 5G to stay connected. Additional perks include Samsung Wallet, Samsung TV Plus, and 6 OS upgrades with 6 years of security updates for lasting protection and value.
Both devices are now available online and in Optimum retail stores, joining the latest Samsung Galaxy S Series in Optimum's growing lineup of premium devices.
The Samsung Galaxy Tab A11+ 5G joins the portfolio of tablets available at Optimum Mobile which delivers affordable mobile and tablet plans on America's largest and fastest 5G network. Customers can get a Tablet Unlimited plan for just $10/month for 12 months when customers add a new line of Tablet Unlimited and finance the new tablet. This offer is available to new and existing Optimum Mobile customers through January 22, 2026.
For complete pricing and availability details, please visit Optimum.com/mobile or an Optimum store.
* * *
Original text here: https://www.optimum.com/about-us/news/articles/optimum-mobile-expands-device-lineup-all-new-samsung-galaxy-tab-a11-5g-and-samsung
[Category: BizComputer Technology]
Marcus & Millichap Brokers Sale of Multifamily Portfolio in Upper Manhattan
ENCINO, California, Jan. 10 -- Marcus and Millichap issued the following news release:
* * *
Marcus & Millichap Brokers Sale of Multifamily Portfolio in Upper Manhattan
NEW YORK, Jan. 9, 2026 - Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of Finite Homes portfolio, a Harlem-based multifamily portfolio consisting of 14 buildings and one vacant lot.
"After being under contract for more than two years, we were finally able to close with an affordable housing
... Show Full Article
ENCINO, California, Jan. 10 -- Marcus and Millichap issued the following news release:
* * *
Marcus & Millichap Brokers Sale of Multifamily Portfolio in Upper Manhattan
NEW YORK, Jan. 9, 2026 - Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of Finite Homes portfolio, a Harlem-based multifamily portfolio consisting of 14 buildings and one vacant lot.
"After being under contract for more than two years, we were finally able to close with an affordable housingbuyer who jumped through more hoops than I can count," said Seth Glasser of Marcus & Millichap's New York Multifamily Group in Manhattan. "The buyer's willingness and expertise to navigate HPD was truly exceptional," added Michael Fusco.
Glasser and Fusco exclusively marketed the portfolio on behalf of the seller, Finite Homes LLC, and procured the buyer, Heritage Affordable.
The Finite Homes portfolio includes 130 apartments and six retail spaces, with the properties concentrated along 125th Street, Harlem's primary commercial corridor. The residential mix ranges from studios to four-bedroom units, and five of the six retail spaces provide street-level exposure along the corridor.
The properties have direct access to multiple subway lines and proximity to major neighborhood anchors, including the Apollo Theater, Marcus Garvey Park and Harlem Hospital.
* * *
About Marcus & Millichap, Inc. (NYSE: MMI)
Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. As of December 31, 2024, the company had 1,712 investment sales and financing professionals in over 80 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate. The company also offers market research, consulting and advisory services to clients. Marcus & Millichap closed 7,836 transactions in 2024, with a sales volume of approximately $49.6 billion. For additional information, please visit www.MarcusMillichap.com.
* * *
Original text here: https://www.marcusmillichap.com/news-events/press/2026/01/1-9-finite-homes-portfolio
[Category: BizRealEstate]
Marcus & Millichap Brokers Sale of $14.3M Grocery-Anchored Center in Rocky Hill, Connecticut Despite Complex CMBS Loan Assumption
ENCINO, California, Jan. 10 -- Marcus and Millichap issued the following news release:
* * *
Marcus & Millichap Brokers Sale of $14.3M Grocery-Anchored Center in Rocky Hill, Connecticut Despite Complex CMBS Loan Assumption
ROCKY HILL, Conn., Jan. 9, 2026 - Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of Big Y Plaza, a 60,947-square-foot grocery-anchored shopping center in Rocky Hill, Connecticut, for $14.3 million.
Marcus & Millichap's Joseph C. French Jr.
... Show Full Article
ENCINO, California, Jan. 10 -- Marcus and Millichap issued the following news release:
* * *
Marcus & Millichap Brokers Sale of $14.3M Grocery-Anchored Center in Rocky Hill, Connecticut Despite Complex CMBS Loan Assumption
ROCKY HILL, Conn., Jan. 9, 2026 - Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the sale of Big Y Plaza, a 60,947-square-foot grocery-anchored shopping center in Rocky Hill, Connecticut, for $14.3 million.
Marcus & Millichap's Joseph C. French Jr.and Jeffrey Stearney, in association with John Krueger, the firm's broker of record in Connecticut, exclusively marketed the property on behalf of the seller, a private Connecticut-based company, and procured the buyer, a private New York-based investor.
"The Big Y Plaza has changed hands in a transaction that exemplifies perseverance and collaboration," said French. "The sale was uniquely challenging due to the assumption of an existing commercial mortgage-backed securities loan, a process that required months of approvals and coordination among multiple stakeholders. Despite the extended timeline, both the within the Hartford metropolitan region, providing access for both local and commuter traffic. buyer and seller remained committed to completing the transaction. The successful closing underscores the parties' ability to navigate the complexities of structured financing."
Built in 1988, Big Y Plaza is located at 1030 Elm St. and is fully occupied by two tenants, Big Y Supermarket and Wells Fargo Bank. The center sits on approximately 14.1 acres and includes surface parking. The property is near Interstate 91 and serves a dense residential trade area.
* * *
About Marcus & Millichap, Inc. (NYSE: MMI)
Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. As of December 31, 2024, the company had 1,712 investment sales and financing professionals in over 80 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate. The company also offers market research, consulting and advisory services to clients. Marcus & Millichap closed 7,836 transactions in 2024, with a sales volume of approximately $49.6 billion. For additional information, please visit www.MarcusMillichap.com.
* * *
Original text here: https://www.marcusmillichap.com/news-events/press/2026/01/1-9-big-y-plaza
[Category: BizRealEstate]
Marcus & Millichap Arranges $10.4M Sale of Downtown Winter Garden Mixed-Use Asset
ENCINO, California, Jan. 10 -- Marcus and Millichap issued the following news release:
* * *
Marcus & Millichap Arranges $10.4M Sale of Downtown Winter Garden Mixed-Use Asset
WINTER GARDEN, Fla., Jan. 9, 2026 - Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the $10.4 million sale of Tremaine | Boyd, a mixed-use property consisting of luxury residential units and ground-floor commercial space in Winter Garden, Florida.
The sale of Tremaine Boyd was driven by both the
... Show Full Article
ENCINO, California, Jan. 10 -- Marcus and Millichap issued the following news release:
* * *
Marcus & Millichap Arranges $10.4M Sale of Downtown Winter Garden Mixed-Use Asset
WINTER GARDEN, Fla., Jan. 9, 2026 - Marcus & Millichap (NYSE: MMI), a leading commercial real estate brokerage firm specializing in investment sales, financing, research and advisory services, announced today the $10.4 million sale of Tremaine | Boyd, a mixed-use property consisting of luxury residential units and ground-floor commercial space in Winter Garden, Florida.
The sale of Tremaine Boyd was driven by both thequality of the asset and the continued evolution of downtown Winter Garden as a premier mixed-use destination. "The buyer was drawn to more than just the real estate, they were investing in Winter Garden's story and its long-term growth," said Matthew Prozzillo, Senior Director Investments. "As the original developer, the seller created a landmark asset that helped shape downtown Winter Garden's evolution, making this transaction both a strategic acquisition for the buyer and a successful, vision-validated exit for the seller."
That alignment between asset quality and market fundamentals translated into strong investor demand throughout the marketing process. "The depth and quality of investor interest in Tremaine | Boyd was exceptional, with 19 offers generated in a compressed marketing window from both local and institutional capital," said Ben Skinner, Senior Director Investments. "Achieving a record-setting price per unit for the Orlando MSA underscores the scarcity of true mixed-use product in downtown Winter Garden and the conviction investors have in this market's long-term trajectory."
Prozzillo, Skinner, Alex Goodale and Salim Valiani, investment specialists in Marcus & Millichap's Orlando office, exclusively marketed the property on behalf of the seller, who was the original developer, and procured the buyer, a New York-based family office.
Built in 2019, the three-story property is located at 109 S. Boyd St. in historic downtown Winter Garden. The asset includes 22 residential units, with two commercial tenants occupying the ground floor. The property is one block off Plant Street, the city's primary commercial corridor, adjacent to the SOBO Art Gallery and directly across from the nationally recognized Winter Garden Farmers Market.
* * *
About Marcus & Millichap, Inc. (NYSE: MMI)
Marcus & Millichap, Inc. is a leading brokerage firm specializing in commercial real estate investment sales, financing, research and advisory services with offices throughout the United States and Canada. As of December 31, 2024, the company had 1,712 investment sales and financing professionals in over 80 offices who provide investment brokerage and financing services to sellers and buyers of commercial real estate. The company also offers market research, consulting and advisory services to clients. Marcus & Millichap closed 7,836 transactions in 2024, with a sales volume of approximately $49.6 billion. For additional information, please visit www.MarcusMillichap.com.
* * *
Original text here: https://www.marcusmillichap.com/news-events/press/2026/01/1-9-tremaine-boyd
[Category: BizRealEstate]
Hooper, Lundy and Bookman Issues Commentary: FDA's New Digital Health Guidance Signal Shift for Wellness Devices and CDS
LOS ANGELES, California, Jan. 10 -- Hooper, Lundy and Bookman, a law firm, issued the following commentary on Jan. 9, 2026:
* * *
FDA's New Digital Health Guidance Signal Shift for Wellness Devices and CDS
On January 6, 2026, the Food and Drug Administration (FDA) released updated guidance on Clinical Decision Support Software, as well as General Wellness: Policy for Low Risk Devices, providing clarity to an industry grappling with innovation and regulatory expectations. Both guidance documents contain additional explanation from the FDA on the definitions and applicable regulations which apply
... Show Full Article
LOS ANGELES, California, Jan. 10 -- Hooper, Lundy and Bookman, a law firm, issued the following commentary on Jan. 9, 2026:
* * *
FDA's New Digital Health Guidance Signal Shift for Wellness Devices and CDS
On January 6, 2026, the Food and Drug Administration (FDA) released updated guidance on Clinical Decision Support Software, as well as General Wellness: Policy for Low Risk Devices, providing clarity to an industry grappling with innovation and regulatory expectations. Both guidance documents contain additional explanation from the FDA on the definitions and applicable regulations which applyto general wellness products and clinical decision support (CDS) software. While FDA notes the guidance is nonbinding and merely represents the FDA's current recommendations and statutory interpretations, it is intended to provide an understanding of what enforcement actions the Administration will undertake. The guidance is part of a larger initiative from the Trump Administration to both deregulate and encourage use of digital health products. Although the guidance limits those products under FDA's regulatory purview, it will be important for providers to be aware of where their devices fall within regulatory definitions as the digital health policy landscape continues to adapt to its current pressures through further policymaking.
General Wellness Products
The FDA's Center for Devices and Radiological Health released updated guidance (last revised in 2019) for low-risk general wellness products. The agency specifically defines general wellness products as those that relate to maintaining a general state of health or the role of a healthy lifestyle to reduce the risk of certain chronic diseases. These products also must present a low risk to the safety of users.
Building off its previous guidance, FDA describes its categories of intended uses in two ways, (1) those claiming to sustain or improve functions associated with a general state of health that do not make any reference to diseases or condition, such as weight management, physical fitness, stress management, mental acuity, self-esteem, sleep management or sexual function and (2) those that make reference to diseases or conditions and are intended to help reduce the risk of and manage certain chronic conditions. The FDA guidance establishes a standard that products must not be invasive, implanted, or pose a risk to the safety of the user.
The guidance responds to an increased need for clarification that certain non invasive sensing features in wearables--such as optical sensors that estimate blood pressure, oxygen saturation, blood glucose trends, or heart rate variability--may be treated as general wellness products, rather than medical devices, when the products are intended only for wellness-related use. The FDA provides specific examples of wrist-warn wearables and their applications.
The FDA emphasized that the goal of the guidance is to give companies clear boundaries so that devices that simply provide information--without presenting themselves as medical-grade tools--can operate without FDA oversight. This effort aligns with the Administration's interest in the use of wearables as part of its Make America Health Again initiative, seeking to use innovative means to manage and prevent chronic disease and overall health.
Clinical Decision Support Software
Additionally, FDA released updated guidance (last revised in 2022) outlining a more permissive approach to certain types of clinical decision support (CDS) software, signaling a notable shift from its earlier regulatory stance. The new guidance specifies categories of lower risk CDS tools that will fall outside the scope of medical device regulation, while also clarifying which software functions will continue to be treated as devices.
To qualify as a non device function and therefore not be subject to FDA regulation, CDS software must be:
1. "not intended to acquire, process, or analyze a medical image or a signal from an in vitro diagnostic device or a pattern or signal from a signal acquisition system;
2. intended for the purpose of displaying, analyzing, or printing medical information about a patient or other medical information;
3. intended for the purpose of supporting or providing recommendations to a health care professional about prevention, diagnosis, or treatment of a disease or condition; and
4. intended for the purpose of enabling such health care professional to independently review the basis for such recommendations that such software presents so that it is not the intent that such health care professional rely primarily on any of such recommendations to make a clinical diagnosis or treatment decision regarding an individual patient."
The new guidance clarifies the third criterion for CDS software functions that are excluded from the definition of a medical device under the Food, Drug and Cosmetic Act. The FDA will not enforce regulatory requirements for software that provides a single clinically appropriate recommendation, provided the other criteria are met. Previously, non-device software could only provide a list of treatment recommendations. FDA lists examples that would be subject to enforcement discretion.
Under the FDA guidance, examples of non-device CDS functions include tailored clinician order sets, matching patient medical information, drug formulary guidelines, drug interaction notifications, reminders for preventative care, patient discharge papers, and lists of follow-up options. Examples of items that remain within medical device oversight include software that uses patient images to generate treatment plans, tools that analyze imaging data for surgical planning, and systems that process multiple physiological signals from wearables to detect events such as heart attacks or narcolepsy episodes.
Outlook
The guidance further underscores the Trump Administration's efforts to promote digital health innovation, building on prior announcements, such as the FDA's Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot and the Center for Medicare and Medicaid Innovation's (CMMI's) Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model which would expand access to new technology-supported care to manage chronic disease. Of note, both updated guidance documents were issued without an opportunity to comment beforehand, limiting input. Stakeholders may submit comments for the FDA to consider at any time, but those comments may not be acted upon by the agency until the document is next revised or updated.
-- Monica Massaro and Claire Ernst
* * *
Professional
Monica Massaro
Principal, Government Relations & Public Policy
Washington, D.C.
* * *
Claire Ernst
Director, Government Relations & Public Policy
Washington, D.C.
* * *
Original text here: https://hooperlundy.com/fdas-new-digital-health-guidance-signal-shift-for-wellness-devices-and-cds/
[Category: BizLaw/Legal]
